Have your own idea? Try our Stock Screener
Bangladeshi (DSE) Healthcare Sector Analysis
UpdatedNov 21, 2024
DataAggregated Company Financials
Companies22
- 7D-2.3%
- 3M-7.2%
- 1Y-25.8%
- YTD-25.3%
The Healthcare industry is down 2.3% over the last week with Square Pharmaceuticals the worst performer, down 1.2%. Meanwhile, Navana Pharmaceuticals actually outperformed within the industry, gaining 6.5% in the last week. The industry has fallen 26% in the last year. As for the next few years, earnings are expected to grow by 14% per annum.
Sector Valuation and Performance
Has the Bangladeshi Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Fri, 22 Nov 2024 | ৳414.3b | ৳231.2b | ৳34.2b | 23.2x | 12.1x | 1.8x |
| Sun, 20 Oct 2024 | ৳414.2b | ৳227.4b | ৳32.8b | 20.3x | 12.6x | 1.8x |
| Tue, 17 Sep 2024 | ৳453.9b | ৳229.2b | ৳32.8b | 27.1x | 13.9x | 2x |
| Thu, 15 Aug 2024 | ৳469.5b | ৳229.2b | ৳32.8b | 29.9x | 14.3x | 2x |
| Sat, 13 Jul 2024 | ৳463.4b | ৳226.5b | ৳32.6b | 32.6x | 14.2x | 2x |
| Mon, 10 Jun 2024 | ৳432.1b | ৳226.5b | ৳32.6b | 28.8x | 13.3x | 1.9x |
| Wed, 08 May 2024 | ৳483.2b | ৳223.8b | ৳32.7b | 33.4x | 14.8x | 2.2x |
| Fri, 05 Apr 2024 | ৳476.2b | ৳220.5b | ৳31.6b | 29.9x | 15.1x | 2.2x |
| Sun, 03 Mar 2024 | ৳521.2b | ৳220.5b | ৳31.5b | 35.4x | 16.5x | 2.4x |
| Tue, 30 Jan 2024 | ৳540.3b | ৳216.4b | ৳31.3b | 29.1x | 17.3x | 2.5x |
| Thu, 28 Dec 2023 | ৳550.7b | ৳214.4b | ৳31.1b | 28.9x | 17.7x | 2.6x |
| Sat, 25 Nov 2023 | ৳548.8b | ৳214.5b | ৳31.2b | 32.3x | 17.6x | 2.6x |
| Mon, 23 Oct 2023 | ৳549.7b | ৳207.1b | ৳32.0b | 35.5x | 17.2x | 2.7x |
| Wed, 20 Sep 2023 | ৳550.8b | ৳206.7b | ৳32.0b | 37.7x | 17.2x | 2.7x |
| Fri, 18 Aug 2023 | ৳549.9b | ৳206.7b | ৳32.0b | 37.6x | 17.2x | 2.7x |
| Sun, 16 Jul 2023 | ৳551.0b | ৳206.3b | ৳32.0b | 37.4x | 17.2x | 2.7x |
| Tue, 13 Jun 2023 | ৳549.0b | ৳206.4b | ৳32.1b | 36x | 17.1x | 2.7x |
| Thu, 11 May 2023 | ৳546.1b | ৳205.7b | ৳32.2b | 30.2x | 17x | 2.7x |
| Sat, 08 Apr 2023 | ৳542.5b | ৳201.5b | ৳33.8b | 28x | 16x | 2.7x |
| Mon, 06 Mar 2023 | ৳556.9b | ৳201.5b | ৳33.8b | 29x | 16.5x | 2.8x |
| Wed, 01 Feb 2023 | ৳561.2b | ৳195.6b | ৳33.9b | 29.2x | 16.6x | 2.9x |
| Fri, 30 Dec 2022 | ৳558.9b | ৳194.4b | ৳34.3b | 28.1x | 16.3x | 2.9x |
| Sun, 27 Nov 2022 | ৳561.5b | ৳183.8b | ৳34.7b | 25.2x | 16.2x | 3.1x |
| Tue, 25 Oct 2022 | ৳595.4b | ৳180.0b | ৳35.4b | 25x | 16.8x | 3.3x |
| Thu, 22 Sep 2022 | ৳612.3b | ৳177.0b | ৳35.2b | 29x | 17.4x | 3.5x |
| Sat, 20 Aug 2022 | ৳544.7b | ৳177.0b | ৳35.2b | 25.7x | 15.5x | 3.1x |
| Mon, 18 Jul 2022 | ৳544.9b | ৳177.0b | ৳35.2b | 26.4x | 15.5x | 3.1x |
| Wed, 15 Jun 2022 | ৳554.7b | ৳177.0b | ৳35.2b | 26.7x | 15.8x | 3.1x |
| Fri, 13 May 2022 | ৳567.1b | ৳176.9b | ৳35.2b | 25.9x | 16.1x | 3.2x |
| Sun, 10 Apr 2022 | ৳564.9b | ৳171.6b | ৳34.5b | 25.8x | 16.4x | 3.3x |
| Tue, 08 Mar 2022 | ৳537.5b | ৳171.7b | ৳34.5b | 23.3x | 15.6x | 3.1x |
| Thu, 03 Feb 2022 | ৳571.2b | ৳169.3b | ৳33.6b | 26.4x | 17x | 3.4x |
| Sat, 01 Jan 2022 | ৳551.5b | ৳169.0b | ৳32.7b | 26.1x | 16.9x | 3.3x |
| Mon, 29 Nov 2021 | ৳558.8b | ৳155.4b | ৳29.1b | 29.6x | 19.2x | 3.6x |
Price to Earnings Ratio
19.2x
Current Industry PE
- Investors are pessimistic on the Bangladeshi Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 12.1x which is lower than its 3-year average PE of 16.1x.
- The 3-year average PS ratio of 2.7x is higher than the industry's current PS ratio of 1.8x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have grown 5.6% per year over the last three years.
- Revenues for these companies have grown 14% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Trends
Which industries have driven the changes within the Bangladeshi Healthcare sector?
| BD Market | -0.86% | |
| Healthcare | -2.30% | |
| Healthtech | 0% | |
| Life Sciences | 0% | |
| Pharma | -2.27% | |
| Medical Equipment | -2.89% | |
| Healthcare Services | -3.29% | |
| Biotech | -4.17% | |
Industry PE
- Investors are most optimistic about the Medical Equipment industry even though it's trading below its 3-year average PE ratio of 69.3x.
- It looks like they are confident that earnings will grow faster in the future than they have historically.
Forecasted Growth
- Analysts are most optimistic on the Pharma industry, expecting annual earnings growth of 14% over the next 5 years.
- This is better than its past earnings decline of 2.2% per year.
- In contrast, the Pharma industry is expected to see its earnings grow by 14% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| ORIONINFU Orion Infusion | ৳315.50 | 3.7% +৳232.1m | 3.9% | PE150.4x | |
| NAVANAPHAR Navana Pharmaceuticals | ৳51.50 | 3.4% +৳182.6m | -35.6% | PE13.7x | |
| LIBRAINFU Libra Infusions | ৳902.80 | 7.6% +৳142.8m | 10.7% | n/a | |
| SILCOPHL Silco Pharmaceuticals | ৳15.90 | 1.3% +৳20.8m | -32.1% | PE38.6x | |
| AMBEEPHA Ambee Pharmaceuticals | ৳722.40 | 0.2% +৳2.6m | -8.5% | PE162.3x |